Acumen Pharmaceuticals, Inc.ABOSNASDAQ
Loading
Interest Income Over TimeContracting
Percentile Rank67
3Y CAGR+56.2%
5Y CAGR+519.4%
Studio
Year-over-Year Change

Income earned from interest-bearing assets

3Y CAGR
+56.2%/yr
Annual compound
5Y CAGR
+519.4%/yr
Recent deceleration
Percentile
P67
Within normal range
vs 5Y Ago
9117x
Strong expansion
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$9.12M-36.3%
2024$14.32M+32.7%
2023$10.79M+351.1%
2022$2.39M+2747.6%
2021$84000.00+8300.0%
2020$1000.00-97.8%
2019$45000.00-